Matches in Nanopublications for { ?s ?p "[We previously found that expression of the transcription factor interferon regulatory factor 5 (IRF5) is significantly decreased as a breast lesion progresses from a non-malignant stage to ductal carcinoma in situ and is eventually lost in ~80% of invasive ductal carcinomas examined.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[We previously found that expression of the transcription factor interferon regulatory factor 5 (IRF5) is significantly decreased as a breast lesion progresses from a non-malignant stage to ductal carcinoma in situ and is eventually lost in ~80% of invasive ductal carcinomas examined.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We previously found that expression of the transcription factor interferon regulatory factor 5 (IRF5) is significantly decreased as a breast lesion progresses from a non-malignant stage to ductal carcinoma in situ and is eventually lost in ~80% of invasive ductal carcinomas examined.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1260831.RA_teXceXldrnUH-pmT--cA__34GHmYd_HUGiJ74bzSLE130_assertion description "[We previously found that expression of the transcription factor interferon regulatory factor 5 (IRF5) is significantly decreased as a breast lesion progresses from a non-malignant stage to ductal carcinoma in situ and is eventually lost in ~80% of invasive ductal carcinomas examined.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260831.RA_teXceXldrnUH-pmT--cA__34GHmYd_HUGiJ74bzSLE130_provenance.
- NP1260832.RA5cDErLmbPCEFGhJ8GU_DVboz4TXgwN7d0htTJWiJQrk130_assertion description "[We previously found that expression of the transcription factor interferon regulatory factor 5 (IRF5) is significantly decreased as a breast lesion progresses from a non-malignant stage to ductal carcinoma in situ and is eventually lost in ~80% of invasive ductal carcinomas examined.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260832.RA5cDErLmbPCEFGhJ8GU_DVboz4TXgwN7d0htTJWiJQrk130_provenance.